Share this post on:

Product Name: CAPS2 Antibody
Species Reactivity: Human, Mouse, Rat
Tested Applications: ELISA, IF, IHC-P, WB
Applications: CAPS2 antibody can be used for detection of CAPS2 by Western blot at 0.5 – 1 μg/mL. Antibody can also be used for immunohistochemistry starting at 5 μg/mL. For immunofluorescence start at 20 μg/mL.
User Note: Optimal dilutions for each application to be determined by the researcher.
Predicted Molecular Weight: Predicted: 138, 145 kDa Observed: 150 kDa
Immunogen: CAPS2 antibody was raised against a 19 amino acid synthetic peptide near the center of the human CAPS2.The immunogen is located within amino acids 510 – 560 of CAPS2.
Host Species: Rabbit
Purification: CAPS2 Antibody is affinity chromatography purified via peptide column.
Physical State: Liquid
CAS NO.: 844-26-8
Product: Bithionol (sulfoxide)
Buffer: CAPS2 Antibody is supplied in PBS containing 0.02% sodium azide.
Concentration: 1 mg/mL
Storage Conditions: CAPS2 antibody can be stored at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Clonality: Polyclonal
Conjugate: Unconjugated
Alternate Names: CAPS2 Antibody: CAPS2, KIAA1591, Calcium-dependent secretion activator 2, Calcium-dependent activator protein for secretion 2, CAPS-2
Accession NO.: NP_060424
Protein Ino: 148839294
Official Symbol: CADPS2
Geneid: 93664
Background: CAPS2 Antibody: CAPS2 and the related protein CAPS1 encode novel neural/endocrine-specific cytosolic and peripheral membrane proteins. Both are essential components of the synaptic vesicle priming machinery and are required for the Ca2+-regulated exocytosis of secretory vesicles; CAPS-deficient neurons contain no or very few fusion competent synaptic vesicles, causing a selective impairment of fast phasic transmitter release. Like CAPS1, numerous isoforms of CAPS2 are known to exist. These isoforms show distinct expression patterns in the brain. For example, CAPS2b showed high expression in the developing cerebellum. Furthermore, one version of CAPS2 mRNA that lacks exon 3 is detected in some autistic patients, suggesting that the differential expression pattern of CAPS2 is involved in neuronal development.
PubMed ID:http://aac.asm.org/content/43/4/752.abstract

Share this post on:

Author: Betaine hydrochloride